increased lymphoma incidence_lla<SL/Kh>/lla<SL/Kh>

http://metadb.riken.jp/0012431IAKRJMsSLKhllaSLKhllaSLKhllaSLKh

increased lymphoma incidence_lla<SL/Kh>/lla<SL/Kh>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• lymphoma latency acceleration
  http://metadb.riken.jp/db/mgi_rdf/MGI:1096375

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• lla<SL/Kh>/lla<SL/Kh>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• lla<SL/Kh>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: AKR/JMs * SL/Kh

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased lymphoma incidence
  http://purl.obolibrary.org/obo/MP_0012431

文献

http://purl.org/net/cito/citesAsAuthority

• T. Kamoto, et.al., A quantitative trait locus in major histocompatibility complex determining latent period of mouse lymphomas., Japanese journal of cancer research : Gann, 1996, 87
  http://rdf.ncbi.nlm.nih.gov/pubmed/8641972
• H. Hiai, et.al., To be or not to be a T-lymphomas, that is determined by a dominant gene Tlsm-1 in mouse models., Leukemia, 1997, 11 Suppl 3
  http://rdf.ncbi.nlm.nih.gov/pubmed/9209340